We are live on ! Find out more
CPHR

Cipher Pharmaceuticals Inc.
CPHR

Delisted

CPHR was delisted on the 8th of December, 2016.

21 hedge funds and large institutions have $36.8M invested in Cipher Pharmaceuticals Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

28% more capital invested

Capital invested by funds: $28.6M → $36.8M (+$8.12M)

13% less funds holding

Funds holding: 2421 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
9
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
26
Barclays
United Kingdom
-$1K -300 Closed
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
+$190 +44 New

CPHR Hedge Fund Activity: Q4 2015 in Review

21 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q4 2015, worth a combined $36.8M — up 28% from $28.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CPHR and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 9 added.

The largest buyer was Grandeur Peak Global Advisors, adding an estimated $2.55M. The largest seller was O'Shaughnessy Asset Management, exiting entirely with an estimated $2.36M sold.

  • 21 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q4 2015, down from 24 in Q3 2015.
  • Funds reported $36.8M of Cipher Pharmaceuticals Inc. stock for Q4 2015, up 28% quarter-over-quarter.
  • 4 funds opened new Cipher Pharmaceuticals Inc. positions in Q4 2015 and 7 closed out, a net change of -3 holders.
  • The largest Cipher Pharmaceuticals Inc. buyer in Q4 2015 was Grandeur Peak Global Advisors, an estimated $2.55M added.
  • The largest Cipher Pharmaceuticals Inc. seller in Q4 2015 was O'Shaughnessy Asset Management, an estimated $2.36M sold.

Based on aggregated 13F filings for Q4 2015.